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The synthesis of2-[(4-aminophenyl)sulfonyl] derivatives of benzimidazole 1 benzothiazole 2 and 6-
methyluracil 5 has been accomplished via KMn04-oxidation of the corresponding 2-(4-nitrophenyl)thio
derivatives to the sulfones followed by dissolved-metal reduction of the nitro group. The synthesis of the
2, 4-diaminophenyl congeners 3, 4 and 6, on the other hand, has been carried out by initial reduction of
the nitro groups in the 2-(2, 4-dinitrophenyl)thio derivatives, followed by acetylation of the produced
aminosulfides, oxidation to the acetylaminosulfones and finally deacetylation. The antimicrobial activity
of compounds 1-5 against Escherichia coli is comparable to that of the antileprotic drug Dapsone.
Only few drugs are available for the treatment and
control of human leprosy, a chronic infectious dis-
ease caused by Mycobacterium leprae', Of these
drugs, Dapsone (4, 4'-diaminodiphenylsulfone;
DDS) has been found, since 1947, to be the only
drug effective in the management of this agonizing
illness2. However, the possible development of
bacterial resistance and the high toxicity of DDS
necessitated the search for new antileprotic agents'.
Several SAR studies have been reported'" on DDS
and related compounds with the premise that these
diaryl sulfones can have important role as antibac-
terial and antimalarial agents? Diary sulfones, like
sulfonamides, exert their biological action by in-
hibiting dihydropteroate synthase competitively
with respect to the substrate 4-aminobenzoate
(PABAl ortho-substitution to the sulfuryl group
with electron releasing groups such as NH2 or OH
increases the activity presumably by increasing
electron density on the S02 group (so as to mimic
CO; of PABA5) and/or by anchoring the molecule
into a pharmacophoric conformation through in-
tramolecular hydrogen bonding". In addition, or-
tho-substitution is reported to inhibit metabolic
t Presented in part at the 24th conference of Pharmaceutical
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5 Y = 4-NH2
6 Y = 2,4-diNH2
oxidation of diaminodiaryl sulfones to cytotoxic
hydroxylamines'.
The objectives of this study are to synthesize a
number of 4-amino or 2, 4-diaminophenylsulfonyl
derivatives of benzimidazole, benzothiazole and 6-
methyluracil (compounds 1-6) and to evaluate the
antimicrobial activity of these heteroaryl sulfones
against Escherichia coli in comparison to DDS.
Naturally, the replacement of a phenyl group by a
heterocyclic ring as in compounds 1-6 can have a
pronounced effect on the physiochemical and
stereochemical properties of this class of com-
pounds which in turn can affect transport and
binding. Part of this effect can be envisioned by a
possible variation of electron density on the S02
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group and by intramolecular hydrogeri bonding as
described for 2-NH2 or 2-0H substituent.
Chemistry
Synthesis of the target compounds 1-6 is illus-
trated in Schemes I (1-4) and II (5 and 6). In
Scheme I, the reaction of benzimidazole-2-thiol 7
with l-chloro-4-nitrobenzene in alkaline aqueous
n-propanol gave 4-nitrophenylthiobenzimidazole 9
in 63% yield", Likewise, the reaction of 7 with 1-
chloro-2, 4-dinitrobenzene in ethanolic KOH gave
80% of the dinitro derivative 1110,11. Nitro- and.
dinitrophenyl thioethers of benzothiazole 10 and
12 . 1 d . '1 1 II 12 N', respective y, were prepare sum ar y '. 1-
trophenyl thioethers 9 and 10 were readily oxidized
to the corresponding sulfones 13 and
14,respectively, using KMn04/acetic acid13• Re-
duction of 13 or 14 with FelHCl in ethanol af-
fected selective reduction of the nitro group to give
the desired aminophenyl sulfones 1 and 2, respec-
tively. On the contrary, their dinitro counterparts
11 and 12 resisted several attempts for oxidation to
the corresponding sulfones (using KMn04/AcOH,
H202/AcOH or MCPBA) probably due to dimin-






cordingly, compounds 11 and 12 were initially re-
duced (FeIHC1) to the aminosulfides 15 and 16
protected by acetylation to 17 and 18, oxidized
(MCPBA) to the acetylaminosulfones 19 and 20
and finally deprotected to give the diaminosulfones
3 and 4, respectively. Acetyl group at N-l of the
intermediate 17 was cleaved possibly during work-
up procedures of the oxidation step.
During the unsuccessful attempts for the oxida-
tion of thioethers 11 and 12 to the corresponding
sulfones, it was observed that heating (12 hours at
80°C) of 11 in H202/AcOH resulted in sulfide bond
cleavage to give 2-hydroxybenzimidazole (45%)
and another side product which was identified
(m.p.!", IR, NMR) as 2, 2', 4, 4'-,
tetranitrodiphenyldisulfide (48%) (Scheme III).
Significantly, identical treatment of 12 resulted in
no such cleavage and the benzothiazole thioether
was recovered unchanged. It is conceivable that
sulfide cleavage resulted from SNAr type reaction
in which the first step (rate determining'") is a nu-
cleophilic attack (probably by H20) at C-2 of the
hetero ring followed by fast departure of the dini-
trophenylthiolate anion. In benzimidazole thioether
11, the first step is accelerated by the strong -I ef-
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a) I-CI-4-N02CJ-I4, I-butanol, reflux;
b) l-CI-2,4-di N02CJ-I3, DMF, 70°C;
c) KMn04/ AcOH;




·Position of Ac group is uncertain (N-l or N-3)
Scheme II
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Scheme III-Proposed mechanism for sulfide bond cleavage in 11 and disulfide formation.
feet of the two nitrogen atoms, a condition which is
not quite permissible to the benzothiazole conge-
ner. It was also significant to observe that nucleo-
philic attack occurred at C-2 of the benzimidazole
system rather than at' C-l of the phenyl ring as the
most electropositive center irregardless to the pos-
sibly good-leaving heterothiolate anion. The above
observations, in fact, emphasize and demonstrate
nucleophilic attack as the rate determining step in
SNAr reactions". Naturally, the presence of an oxi-
dant (H202) and prolonged heating promoted disul-
fide production'".
The above considerations regarding sulfide
cleavage and disulfide formation gained further I
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support as these side reactions became more pro-
nounced during the synthesis of 4-amino- and 2,.4-
diaminophenylsulfonyluracils 5 and 6 (Scheme II).
In this case, the disulfide production was encoun-
tered during several attempts for the preparation
and oxidation of 4-nitro- and 2, 4-dinitro-
phenylthiouracils 22 and 23, respectively. For ex-
ample, when 6-methyl-2-thiouracil sodium salt 21
was refluxed in DMF for 1 hr with l-chloro-4-
nitrobenzene, there were quantitative conversions
to 4, 4'-dinitrodiphenyldisulfideI6 and 6-
methyluracil. Apparently, the more electropostive
C-2 of the thiouracil ring constituted a better sub-
strate (than in case of 11) for nucleophilic attack. In
addition, and perhaps more significantly, is the
possible stabilization of the Meisenheimer complex
brought about by the distribution of the negative
charge on the oxygen atom of the carbonyl group.
Nevertheless, it was possible to optimize the reac-
tion conditions to obtain 4-nitrophenylthiouracil 22
in 46% yield (together with 20% of the disulfide
bt-product)by conducting the reaction in n-butanol
for 40 hr. Also, thioether 23 was obtained in a good
yield when prepared in DMF at 70°C. Oxidation of
22 (KMn04/AcOH) gave 33% of sulfone 24 in ad-
dition to 65% of the disulfide side product. Reduc-
tion of 24 provided the aminophenylsulfone 5. As
in the case of dinitrophenyl thioethers 11 and 12,
compound 23 resisted oxidation to the sulfone. In
one attempt, it was heated with H202/AcOH to
produce only uracil and disulfide. Therefore, the
target compound 6 was obtained via the same syn-
thetic approach resorted to for the synthesis of
compounds 3 and 4. 1H NMR analysis of the ace-
tylated product 26 showed that one of the pyrimi-
dine nitrogens was also acetylated; however, the
location of the acetyl group (N-I or N-3) could not
be ascertained.
Results and Discussion
The search for new anti leprotic agents is ren-
dered difficult by the current inability to cultivate
M/eprae in vitro. The most widely used model for
screening new drugs is the growth of M /eprae in
mouse foot pads" However, the bacteriostatic ef-
fect of DDS on E. coli may be related to its anti-
mycobacterium activity since, in both cases, it was
proven that DDS has the same mechanism of ac-
tion, i.e. inhibition of folate synthesis". Accord-
ingly, the antimicrobial activity of the tested com-
pounds was evaluated against E.coli using the agar
diffusion method using DDS as standard. The re-
sults are expressed as the diameter of inhibition
zone as shown in Table I. All the 4-amino- and 2,
4-diaminophenylsulfonyl derivatives 1-5 (com-
pound 6 was not tested) showed antimicrobial ac-
tivity comparable to that of DDS, irrespective to
the nature of the heterocyclic moiety. Unlike diaryl
sulfones, the 2, 4-diamino compounds were not
more active than the 4-amino compound. Whether
this activity was blocked or reversed by PABA (to
denote a sulfonamide mechanism'') was not inves-
tigated. However, to examine the importance of p-
aminophenylsulfonyl moiety, several other syn-
thetic intermediates in which this moiety was
modified were tested. The results (Table I) showed
that the antimicrobial activity was maintained in all
the tested derivatives (which included diacetylami-
nophenyl sulfones or sulfides and diamino or dini-
trophenyl sulfides). Since these modifications (ex-
cept acetylation) are known to diminish or abolish
the activity in diaryl sulfones':", it is unlikely,
therefore, that the activity of 1-5 is associated with
the p-aminophenylsulfonyl moiety or -for that
matter-follows an antifolate mechanism. It is pos-
sible, however, that the exhibited antimicrobial
activity is related -more closely- to the heterocyclic
structure as, for example, some 2-arylthio deriva-
tives of benzimidazole and benzothiazole are re-
ported9,19 to possess antimicrobial and antifungal
activities. It is also conceivable that the activity of
the thiouracil derivatives (e.g., compound 22 or 23)
can be brought about by a mechanism which would
involve inhibition of protein or nucleic acid bio-
synthesis".
In conclusion, this study showed that replace-
ment of a p-aminophenyl moiety in DDS with a
heterocyclic structure as in compounds 1-5 main-
tained an antimicrobial activity against E. coli
which is equal in potency to DDS but probably of a
different mode of action. Further studies on the
activity and cytotoxicity of these compounds are
worthwhile, in particular with the increasing inter-
est for the use of diaryl sulfones in the chemother-
apy of HIV -related infections".
Experimental Section
General. Melting points were determined in
capillary tubes using a Griffin apparatus and are
uncorrected. Elemental analyses were carried out at
the Microanalytical Center, Cairo University,
Cairo, Egypt. Infrared spectra were measured on a
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Table I - Physical properties and antimicrobial activity of 2-substituted benzimidazole, benzothiazole and 6-methyl-2-uracil




Compd Het X Y Zone of Yield mp Recryst
inhibition (mm)* (%) °C solvent
1 2-Benzimidazolyl S02 4-NH2 20 54 240 EtOH
2 2-Benzothiazolyl S02 4-NH2 21 59 209-212 EtOH
3 2-Benzimidazolyl S02 2,4-diNH2 19 35 >300 EtOH
4 2-Benzothiazolyl S02 2,4-diNH2 19 50 >300 EtOH
5 6-Me-2-uracilyl S02 4-NH2 19 30 260-263 EtOH-H2O
15 2-Benzimidazolyl S 2,4-diNH2 20 56 210-211 H2O
16 2-Benzothiazolyl S 2,4-diNH2 19 52 123-125 EtOH
17 I-Ac-2-Benzimidazolyl S 2,4-diNHAc 19 86 227-229 MeCN
18 2-Benzothiazolyl S 2,4-diNHAc 18 85 185-187 EtOH-H2O
19 2-Benzimidazolyl S02 2,4-diNHAc 20 56 240-244 EtOH
20 2-Benzothiazolyl S02 2,4-diNHAc 21 77 135-137 EtOH-H2O
22 6-Me-2-uracilyl S 4-N02 20 46 255-260 Me2CO
23 6-Me-2-uracilyl S 2,4-diN02 20 83 211-213 benzene
25.2HCI 6-Me-2-uracilyl S 2,4-diNH2 20 49 285-287 EtOH
26 1(3)-Ac-6-Me-2-uracilyl S 2,4-diNHAc 20 86 223-225 EtOH-H2O
27 1(3 )-Ac-6-Me-2-uracilyl S02 2,4-diNHAc 19 48 305 EtOH
Dapsone(DDS) 22
-Average of2 or more determinations using 20 mglmL of the test compound or DDS.
Shimadzu IR 435 spectrometer. Proton magnetic
resonances CH NMR) were measured at 90 MHz
on a Jeol FX 90 spectrometer using tetramethylsi-
lane as internal standard (chemical shifts are re-
ported in 8 ppm). Mass spectra were obtained on a
Hewlett Packard 5988 spectrometer.
Benzothiazole-2-thiol was obtained commer-
cially. The following compounds were prepared
according to the reported procedures: Benzirnidaz-
0Ie-2-thiot22 7, 2-[( 4-nitrophenyl)thio [benzimida-
zole" 9, 2-[( 4-nitrophenyl)thio [benzothiazole" 10,
2-[(2, 4-dinitrophenyl)thio]benzimidazole!O 11, 2-
[(2, 4-dinitrophenyl)thio [benzothiazole'! 12, 2-[(4-
nitrophenyl)sulfonyl]benzimidazoleI3 13, 2-[(4-
nitrophenyl)sulfonyl]benzothiazoleI3 14 and 6-
methyl-2-thioxo-2, 3-dihydro-4( IH)-pyrimidinone
sodium salt23 21.
m-Chloroperbenzoic acid was always freshly
prepared as reported".
6-Methyl-2-[ (4-nitrophenyl) thio]-4(1H)-pyri-
midinone 22. To a boiling solution of 21 (1.6g,
0.01 mole) in l-butanol (50 mL), a solution of 1-
chloro-4-nitrobenzene (2.4 g, 0.0 15 mole) in 1-
butanol (25 mL) was added and the mixture re-
fluxed for 40 hr. The hot reaction mixture was fil-
tered to remove any unreacted 21. The filtrate was
concentrated, cooled, scratched and the separated
solid crystallized from acetone to give 1.2g (46%)
of 22, m.p. 255-60°C; IR (KBr):3400-2700, 1660-
1640 (C=O) 1540, 1340 (N02) ern"; IH NMR
(DMSO-d6): 8.25 (m, J=7.2 Hz, 4H, ArH), 5.92 (s,
IH, C-5H), 2.16 (s, 3H, CH3). Anal. Calcd for
CIIH9N303S: C, 50.19; H, 3.42; N, 15.96. Found:
C, 49.8; H, 3.4; N, 15.5%.
6-Methyl-2-[ (2, 4-dinitrophenyl)thio ]-4(1H)-
pyrimidinone 23. To a solution of 21 (3.2 g, 0.02
mole) in dry DMF (30 mL), a solution of l-chloro-
2, 4-dinitrobenzene (4g, 0.02 mole) in dry DMF (5
mL) was added portionwise with stirring at ambi-
ent temperature. The mixture was stirred at 70°C
for 2 hr, cooled, poured into ice-cold water, filtered
and the separated solid crystallized from benzene
to give 5.1 g (83%) of 23, m.p. 211-13°C; IR
(KBr): 1690 (C=O), 1520, 1340 (N02) cm'; IH
NMR (DMSO-d6): 12.7 (brs, D20 exchangeable),
9.28-8.24 (m, 3H, ArH), 6.56 (s, IH, C-5 H), 2.24
(s, 3H, CH3); ElMS: rnJz 308 (M+) (3.8%), 262
(M+-N02) (100%); Anal. Calcd for CIIH8N40SS:
C, 42.85; H, 2.59; N, 18.18. Found: C, 43.2; H, 2.6;
N,18.2%.
6-M'ethyl-2-[ (4-nitrophenyl) sulfonyl]-4 (1/1)-
pyrimidinone 24-To a stirred ice-cold solution of
22 (0.26 g, 0.001 mole) in glacial acetic acid (20
mL), a solution of KMn04 (0.8 g, 0.005 mole) in
H20 (10 mL) was added portionwise till a perma-
nent pink colour persisted. The reaction mixture
was decolourized by a saturated solution of Na-
HS03 and diluted with ice-cold water. The sepa-
rated solid was washed with benzene to remove the
side product 4, 4'-dinitrodiphenyldisulfide. The
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remaining solid was crystallized from MeOH to
give O.lg (33%) of 24, m.p. 280-83°C; IR (KBr):
3100 (NH), 1660 (C=O), 1540, 1350 (N02), 1350,
1160 (S02) ern". Anal. Calcd for Cl1H9N305S:





rimidinone 5. To a mechanically stirred boiling
mixture of the appropriate 4-nitrophenylsulfonyl
derivative 13, 14 or 24 (0.025 mole), iron powder
(0.15 mole) and EtOH (150 mL), a solution ofHCI
(3 mL) in EtOH (10 mL) was added dropwise over
a period of 15 min. The mixture was refluxed for
an additional period of 3.5 hr, cooled, rendered al-
kaline with ethanolic KOH (15%) and filtered. The
filtrate was concentrated, and the separated solid
purified by crystallization to give the respective
aminophenylsulfonyl derivatives 1, 2 and 5.
Compound 1: Yield 54%, mp 240°C (EtOH);
IR (KBr): 3380, 3100-2300, 1630 (NH, NH2),
1350, 1150 (S02) cm"; IH NMR (OMSO-d6): 9.4
(s, IH, NH of benzimidazole, 020 exchangeable),
8.24-6.4 (m, ArH and NH2 exchangeable protons);
ElMS: mlz 273 (M+) (71.5%), 209 (M+-S02)
(100%). Anal. Calcd for CI3HIIN302S: C, 57.14; H,
4.04; N, 15.38. Found: C, 57.2; H, 4.4; N; 15.1%.
Compound 2: Yield 59%, mp 209-12°C
(EtOH); IR (KBr); 3450, 3350, (NH2), 1350, 1150
(S02) cm'; IH NMR (OMSO-d6): 8.8-8.4 (m, 2H,
ArH), 8.32-7.84 (m, 4H, ArH), 7.2-6.64 (m, 4H,
ArH and NH2 exchangeable protons); ElMS. mlz
290 (M+) (21.4%), 226 (M+-S02) (100%). Anal.
CaIcd. for C13HION202S2: C; 53.79, H; 3.44; N,
9.65. Found: C, 54.1; H~3-7; N, 9.9%.
Compound 5: Yield 30%, mp 260-63°C (aque-
ous EtOH); IR (KBr): 3450, 3250 (NH, NH2),
1645-1630 (C=O), 1150-1130 (S02) cm'; 'H
NMR (OMSO-d6): 7.9 (d, J=9 Hz, 2H, ArH), 6.96
(d, J=9 Hz, 2H, ArH), 6.44 (s, IH, C-5 H), 2.64 (s,
3H, CH3); ElMS: mlz 265 (M+) (0.4%), 200 (M+-
S02H) (100%). Anal. CaIcd for CIIHIlN303S: C,
49.85; H, 4.15; N, 15.84. Found: C, 50.1; H; 4.3;
N,15.5%.
2-[(2, 4-0iaminopheny1)thio ]benzimidazole 15,
2-[(2, 4-diamino-phenyl)thio ]benzothiazole 16 and
6-methyl-2-[2, 4-diaminophenyl)thio ]-4( IH)-pyri-
midinone. 2HCI (25. 2HCI). These compounds
were prepared from the respective nitro derivatives
11, 12 and 23 following the same procedures as
described for the synthesis of compounds 1, 2 and
5. Compound 25 was isolated as its dihydrochlo-
ride salt.
Compound 15: Yield 56%, m.p. 210-11°C
(H20); IR (KBr): 3550, 3450, (NH, NH2) cm'; IH
NMR (OMSO-d6): 12.5 (brs, IH, 020 exchange-
able), 7.84-6.4 (m, 7H, ArH), 6.0 (brs, 2H, 020
exchangeable, NH2), 5.04 (brs, 2H, 020 exchange-
able, NH2); ElMS: mlz 256 (M+) (97%). Anal.
Calcd for C13HI2N4S: C, 60.93; H, 4.68; N, 21.87.
Found: C, 60.6; H, 4.7; N, 21.4%.
Compound 16: Yield 52%, mp 123-25°C
(EtOH); IR (KBr): 3450-3200, (NH2) crn'"; IH
NMR (OMSO-d6): 8.4-7.2 (m, 5H, ArH), 6.32 (m,
2H, ArH), 5.6 (s, 2H, 020 exchangeable), 5.76 (s,
2H, 020 exchangeable); ElMS: mlz 273 (M+)
(67%). Anal. CaIcd for C13HIlN3S2: C, 57.14; H,
4.02; N, 15.38. Found: C, 56.8; H, 3.9; N, 15.4%.
Compound 25. 2HCl: Yield 49%, m.p. 285-
87°C (EtOH); IR (KBr): 3400, 3350, 3200 (NH,
NH2) 1660 (C=O) cm'; IH NMR (OMSO-d6): 9.36
(s, 1H), 8.96-5.6 (m, 8H), 2.2 (s, 3H, CH3); ElMS
m/z 216 (M+-S) (78.7%). Anal. CaIcd for
CIIH12N40S.2HCI: C, 4l.l2; H, 4.36; N, 17.44.
Found: C, 40.8; H, 4.3; N, 17.1%.
l-Acetyl-2-[ (2, 4-diacetylaminophenyl)thio]-
benzimidazole 17, 2-[(2, 4-diacetylaminophe-
nyl)thio]benzothiazole 18 and 1(3)-acetyl-6-
methyl-2- [(2,4-diacetylaminophenyl)thio ]-4(lH)-
pyrimidinone 26. A mixture of the amino-
phenylthioether 15, 16 or 25. 2HCI (0.002 mole)
and AC20 (0.05 mole) was heated in a boiling wa-
ter-bath for 1 hr [in case of 25. 2HCI, anhydrous
sodium acetate (0.006 mole) was added to the re-
action mixture prior to heating]. The mixture was
cooled, poured into ice-cold water and the precipi-
tated solid filtered and purified by crystallization.
Compound 17: Yield 86%, mp 227-29°C
(MeCN); lR (KBr):3200 (NH) 1710, 1680 (C=O)
cm'"; IH NMR (OMSO-d6): 10.64 (brs, 020 ex-
changeable), 9.6 (brs, 020 exchangeable), 8.6-7.4
(m, 7H, ArH), 3.0 (s, 3H, COCH3),2.18(s, 3H,
COCH3), 2.08(s, 3H, COCH3)' Anal Calcd for
C19H18N403S:C, 59.67; H, 4.74; N, 14.65. Found:
C, 59.6; H, 4.4; N. 15.0%.
Compound 18:Yield 85%, mp 185-87°C (aque-
ous EtOH); IR (KBr):3450-3100 (NH), 1680-1660
(C=O) crn"; 'H NMR (OMSO-d6): 10.8(s, IH, NH,
020 exchangeable), 10.24 (s, IH, NH, 020 ex-
changeable), 8.64-7.44 (m, 7H, ArH), 2.24 (s, 3H,
COCH), 2.16 (s, 3H, COCH3)' Anal. Calcd for
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C17HISN302S2:C, 57.14; H, 4.2; N, 11.76. Found:
C, 57.1; H, 4.0; N, 11.8%.
Compound 26: Yield 86%, mp 223-25°C
(aqueous EtOH); IR (KBr):3450-3250 (NH), 1695,
1670 (C=O) em"; IH NMR (COCh): 9.6 (d, J=9
Hz, IH, C-6 H of Ph ring), 7.76 (m, 2H, ArH), 6.56
(s, IH, C-5 H), 2.52 (s, 6H, CH3 protons) 2.4 (s,
6H, CH3protons). Anal. Calcd for C17HISN404S:C,
54.54; H, 4.81; N, 14.97. Found: C, 54.2; H, 4,7;
N,14.9%.
2-{(2, 4-Diacetylaminopbenyl)sulfonyl] benzi-
midazole 19, 2-[(2, 4-diacetylaminopbenyl)-
sulfonyl]benzotbiazole 20 and 1(3)-acetyl-6-
metbyl-2-[ (2, 4-diacetylaminopbenyl)sulfonyl]-
4(IH)-pyrimidinone 27. To a stirred ice-cold so-
lution of the respective acetylaminophenylthioether
17, 18 or 26 (0.003 mole) in either OMSO (25 mL)
(in case of 17) or CH2Ch (25 mL) (in case of 18
and 26), a solution of MCPBA (0.0075 mole) in
CH2Ch (25 mL) was added portionwise over a pe-
riod of 15 min. The mixture was stirred at room
temperature for 48 hr and washed with saturated
solutions of NaHS03 and NaHC03 and then with.
water._ The organic layer was dried (Na2S04),
evaporated and the residue purified by crystalliza-
tion.
Compound 19: Yield 56% mp 240-44°C
(EtOH); IR: 3200 (NH), 1715, 1680-1650 (C=O),
1345, 1155 (S02) cm'; IH NMR (OMSO-d6):
10.64 (s, IH, 020 exchangeable), 10.24 (s, IH,
020 exchangeable), 8.4-7.2 (m, 7H, ArH), 2.2 (s,
6H, 2COCH3); ElMS: m/z 371 (~-1) (0.4%) 265
(M+-Ac and S02) (100%). Anal. Calcd for
C17HI6N404S:54.83; H, 4.3; N, 15.05. Found: C,
54.9; H, 4.7%.
Compound 20: Yield 77%, mp 135-37°C
(aqueous EtOH); IR(KBr): 3100-2500 (NH), 1690
(C=O), 1350, 1145 (S02) cm'; IH NMR (OMSO-
d6): 10.88 (s, IH, NH, 020 exchangeable), 10.64
(s, IH, NIt 020 exchangeable)" 8.8-7.76 (m, 7H,
ArH), 2.2 (s, 6H, 2 COCH3)' Anal. Calcd for'
C17HISN304S2:C, 52.44; H, 3.85; N, 10.79. Found:
C, 52.5; H, 3.5; N, 10.9%.
Compound 27: Yield 48%, mp 305°C (EtOH);
IR (KBr) 3400-3150 (NH), 1695-1660 (C=O),
1365 (S02) cm'; Anal. Calcd for C17HISN406S:C,
50.24; H, 4.43; N, 13.79. Found: C, 49.9; H, 4.2;
N,13.5%.
2-[(2, 4-Diaminopbenyl)sulfonyl] benzimida-
zole 3, 2-[(2, 4-diaminopbenyl)sulfonyl]benzo-
tbiazole 4 and 6-metbyl-2-[(2, 4-diaminopbenyl)-
sulfonyl]-4(lH}-pyrimidinone 6. To a boiling so-
lution of the respective acetyl derivative 19, 20 or
27 (0.001 mole) in EtOH (20 mL) a solution of
HCl (2.5 mL) in EtOH (10 mL) was added drop-
wise. The reaction mixture was refluxed for 3 hr,
cooled, rendered alkaline by dropwise addition of
EtOHIKOH (15%) and filtered. The filtrate was
evaporated and the residue crystallized from EtOH.
Compound 3: Yield 35%, mp >300°C (EtOH);
IR (KBr): 3200 (NH2) em"; IH NMR (OMSO-d6):
8.24-7.0 (m, ArH + NH2), 6.32(m, 020 exchange-
able); ElMS: m/z 223 (~-S02H) (100%). Anal.
Calcd for C13H12N402S;C, 54.16; H, 4.16; N,
19.44. Found: C, 53.9; H, 4.0; N, 19.1%.
Compound 4: Yield 50%, mp>300°C (EtOH);
IR (KBr): 3450-3350 (NH2), 1350, 1140 (S02) ern";
IH NMR (OMSO-d6): 8.36-7.6 (m); ElMS: m/z
305 (M+) (2.1%), 240 (~-S02H) (12.7%). Anal.
Calcd for CI3HllN302S2. C, 51.15; H, 3.61; N,
13.77. Found: C, 50.9; H, 3·.6;N, 13.3%.
Compound 6: Yield 54%, mp >300°C (EtOH);
IR (KBr): 3400-320~, 1640, 1360, 1160 em"; IH
NMR (OMSO-d6): 8:8 (d, J:::I0 Hz, IH, C-6 proton
of Ph ring), 7.28 (s, IH, C-3 proton of Ph ring), 7.0
(d, J:::I0 Hz, IH, C-5 proton of Ph ring), 6.4 (s, IH,
C-5 proton of pyrimidine) 5.84 (s, NH2, 020 ex-
changeable), 2.32 (s, 3H, CH3)' Anal. Calcd for
CllH12N403S:C, 47.14; H, 4.28; N, 20.0. Found:
C, 46.9; H, 4.3; N, 19.8%.
Antimicrobial Activity
Inocula preparation: Escherichia coli NCTC
9002 (E. coli) was grown in nutrient agar (beef ex-
tract, 3.0 g; peptone 5.0 g; agar 15 g/mL) adjusted
to pH 7.0. A viable cell suspension of E. coli after
being harvested in sterile saline was adjusted to
1OS_106cells per.mL using UV spectrophotometer
(Shimadzu UV-160A UV-Vis) ..
Antimicrobial assay.Tested compounds were
dissolved in OMSO to give initial concentration of
20 mg/mL (200 ug/well). Inoculated plates were
incubated at 37°C for 24 hr and the antimicrobial
activity was recorded by measuring the diameter of
zone of inhibition -(in mm). Dapsone was used as
control and a well impregnated with OMSO was
used as negative control.
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